Literature DB >> 2195096

Plasma clearance of heterogeneous growth hormone components in the rat: effects of diabetes and starvation.

T Jolin1, C González.   

Abstract

Two forms of immunoreactive rat GH (rGH), bit rGH (b.rGH) and little rGH (l.rGH) are predominant in both pituitary and plasma from control (C), fasted (F), food-restricted (FR), diabetic (D) and insulin-treated D (D +l) rats. The l.rGH appears to be the predominant form in plasma and pituitary in all five experimental groups. However, in each group, the relative proportion of b.rGH in plasma exceeds from that in pituitary. To determine whether these differences are due to a delayed metabolic clearance of the big component, the MCRs and distribution volume of b.rGH, l.rGH and total rGH were measured in C, F, FR, D and D + l rats. Pituitary extracts, b.rGH and l.rGH were injected as a bolus, and the disappearance of each component was followed by RIA. In each group, the MCR of the big form was significantly lower than that of total rGH and l.rGH. Moreover, MCRs of total rGH, b.rGH and l.rGH in F and D rats were lower than that of the corresponding component in C animals. The decreased b.rGH MCR in each experimental group, and that of total rGH, b.rGH and l.rGH in F and D animals, is associated with a lower distribution space for the above cited components. Furthermore, the reduced receptor-binding activities for the larger form of rGH, and the loss of hepatic GH receptors in D rats, together with the possibility that b.rGH could be presumably excluded from the glomerular filtration and subsequent degradation, may be reasons for the longer persistence of b.rGH in plasma in each experimental group, and for prolonged permanence of l.rGH in plasma in F and D rats.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2195096     DOI: 10.1007/BF03349542

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  22 in total

Review 1.  REVIEW: THE USE OF ISOTOPIC STEROIDS FOR THE MEASUREMENT OF PRODUCTION RATES IN VIVO.

Authors:  J F TAIT
Journal:  J Clin Endocrinol Metab       Date:  1963-12       Impact factor: 5.958

Review 2.  Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review.

Authors:  T Maack; V Johnson; S T Kau; J Figueiredo; D Sigulem
Journal:  Kidney Int       Date:  1979-09       Impact factor: 10.612

3.  Existence of two forms of immunoreactive growth hormone in human plasma.

Authors:  A D Goodman; R Tanenbaum; D Rabinowitz
Journal:  J Clin Endocrinol Metab       Date:  1972-12       Impact factor: 5.958

4.  A stimulatory test for growth hormone release in the rat.

Authors:  N Howard; J M Martin
Journal:  Endocrinology       Date:  1971-02       Impact factor: 4.736

5.  The metabolic clearance, distribution, and degradation of dimeric and monomeric growth hormone (GH): implications for the pattern of circulating GH forms.

Authors:  G Baumann; M W Stolar; T A Buchanan
Journal:  Endocrinology       Date:  1986-10       Impact factor: 4.736

6.  Peptide hormone-induced receptor mobility, aggregation, and internalization.

Authors:  A C King; P Cuatrecasas
Journal:  N Engl J Med       Date:  1981-07-09       Impact factor: 91.245

7.  Polypeptide hormone degradation and receptor regulation are coupled to ligand internalization. A direct biochemical and morphologic demonstration.

Authors:  N Hizuka; P Gorden; M A Lesniak; E Van Obberghen; J L Carpentier; L Orci
Journal:  J Biol Chem       Date:  1981-05-10       Impact factor: 5.157

8.  Plasma "big" and "big-big" growth hormone (GH) in man: an oligomeric series composed of structurally diverse GH monomers.

Authors:  M W Stolar; K Amburn; G Baumann
Journal:  J Clin Endocrinol Metab       Date:  1984-08       Impact factor: 5.958

9.  Diurnal variations of plasma growth hormone, thyrotropin, thyroxine, and triiodothyronine in streptozotocin-diabetic and food-restricted rats.

Authors:  J Ortiz-Caro; C González; T Jolin
Journal:  Endocrinology       Date:  1984-12       Impact factor: 4.736

10.  Plasma clearance of intravenously administered pituitary human growth hormone: gel filtration studies of heterogeneous components.

Authors:  C M Hendricks; R C Eastman; S Takeda; K Asakawa; P Gorden
Journal:  J Clin Endocrinol Metab       Date:  1985-05       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.